{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T01:03:27Z","timestamp":1708563807516},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,21]]},"DOI":"10.7759\/cureus.54627","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T17:43:20Z","timestamp":1708537400000},"source":"Crossref","is-referenced-by-count":0,"title":["A Unique Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Causing Cystic Fibrosis in a Pakistani Child: A Case Highlighting the Need for More Awareness"],"prefix":"10.7759","author":[{"given":"Sinan","family":"Yavuz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basil","family":"Elnazir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saista","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safiya","family":"Saif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Cystic Fibrosis Foundation, Patient Registry Annual Data Report, 2021. (2021). Accessed. 9 June 2023: https:\/\/www.ecfs.eu\/projects\/ecfs-patient-registry\/annual-reports."},{"key":"ref2","unstructured":"The Molecular Genetic Epidemiology of Cystic Fibrosis. Report. (2002). Accessed: February 2024: http:\/\/www.who.int\/genomics\/publications\/en\/HGN_WB_04.02_report.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33337","article-title":"Beyond the local basic panel: full CFTR gene analysis identifies novel CF mutation missed on standard testing in an Arabic child","volume":"15","author":"Francis N","year":"2023","unstructured":"Francis N, Yavuz S, Elnazir B. Beyond the local basic panel: full CFTR gene analysis identifies novel CF mutation missed on standard testing in an Arabic child. Cureus. 2023, 15:e33337. 10.7759\/cureus.33337","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(11)60014-3","article-title":"Recommendations for the classification of diseases as CFTR-related disorders","volume":"10","author":"C Bombieri","unstructured":"C Bombieri, M Claustres, K De Boeck, et al.. Recommendations for the classification of diseases as CFTR-related disorders. Journal of Cystic Fibrosis. 10:102. 10.1016\/S1569-1993(11)60014-3","journal-title":"Journal of Cystic Fibrosis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-008-8083-0","article-title":"Atypical cystic fibrosis and CFTR-related diseases","volume":"35","author":"Paranjape SM","year":"2008","unstructured":"Paranjape SM, Zeitlin PL. Atypical cystic fibrosis and CFTR-related diseases. Clin Rev Allergy Immunol. 2008, 35:116-23. 10.1007\/s12016-008-8083-0","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90353-r","article-title":"Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis","volume":"2","author":"Welsh MJ","year":"1993","unstructured":"Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993, 2:1251-4. 10.1016\/0092-8674(93)90353-r","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2010.05879.x","article-title":"Modifier genes in Mendelian disorders: the example of cystic fibrosis","volume":"1214","author":"Cutting GR","year":"2010","unstructured":"Cutting GR. Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci. 2010, 1214:57-69. 10.1111\/j.1749-6632.2010.05879.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/humu.1191","article-title":"Improved detection of CFTR mutations in Southern California Hispanic CF patients","volume":"18","author":"Wong LJ","year":"2001","unstructured":"Wong LJ, Wang J, Zhang YH, Hsu E, Heim RA, Bowman CM, Woo MS. Improved detection of CFTR mutations in Southern California Hispanic CF patients. Hum Mutat. 2001, 18:296-307. 10.1002\/humu.1191","journal-title":"Hum Mutat"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: from molecular understanding to clinical application","volume":"16","author":"Cutting GR","year":"2015","unstructured":"Cutting GR. Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet. 2015, 16:45-56. 10.1038\/nrg3849","journal-title":"Nat Rev Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(89)80134-9","article-title":"Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus","volume":"114","author":"Kerem E","year":"1989","unstructured":"Kerem E, Corey M, Kerem B, et al.. Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J Pediatr. 1989, 114:767-73. 10.1016\/S0022-3476(89)80134-9","journal-title":"J Pediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.07.016","article-title":"Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis","volume":"131","author":"Blackman SM","year":"2006","unstructured":"Blackman SM, Deering-Brose R, McWilliams R, et al.. Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis. Gastroenterology. 2006, 131:1030-9. 10.1053\/j.gastro.2006.07.016","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181a3bfdd","article-title":"Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: the Israeli Multicenter Study","volume":"50","author":"Efrati O","year":"2010","unstructured":"Efrati O, Nir J, Fraser D, et al.. Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: the Israeli Multicenter Study. J Pediatr Gastroenterol Nutr. 2010, 50:173-8. 10.1097\/MPG.0b013e3181a3bfdd","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21271","article-title":"Does presenting with meconium ileus affect the prognosis of children with cystic fibrosis?","volume":"45","author":"Johnson JA","year":"2010","unstructured":"Johnson JA, Bush A, Buchdahl R. Does presenting with meconium ileus affect the prognosis of children with cystic fibrosis?. Pediatr Pulmonol. 2010, 45:951-8. 10.1002\/ppul.21271","journal-title":"Pediatr Pulmonol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2014.43574","article-title":"Liver disease in cystic fibrosis","volume":"9","author":"Kobelska-Dubiel N","year":"2014","unstructured":"Kobelska-Dubiel N, Klincewicz B, Cichy W. Liver disease in cystic fibrosis. Prz Gastroenterol. 2014, 9:136-41. 10.5114\/pg.2014.43574","journal-title":"Prz Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2007.00250.x","article-title":"Liver disease as risk factor for cystic fibrosis-related diabetes development","volume":"96","author":"Minicucci L","year":"2007","unstructured":"Minicucci L, Lorini R, Giannattasio A, et al.. Liver disease as risk factor for cystic fibrosis-related diabetes development. Acta Paediatr. 2007, 96:736-9. 10.1111\/j.1651-2227.2007.00250.x","journal-title":"Acta Paediatr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.08.006","article-title":"Epidemiology of liver disease in cystic fibrosis: a longitudinal study","volume":"41","author":"Lamireau T","year":"2004","unstructured":"Lamireau T, Monnereau S, Martin S, Marcotte JE, Winnock M, Alvarez F. Epidemiology of liver disease in cystic fibrosis: a longitudinal study. J Hepatol. 2004, 41:920-5. 10.1016\/j.jhep.2004.08.006","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270126","article-title":"A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease","volume":"27","author":"Lindblad A","year":"1998","unstructured":"Lindblad A, Glaumann H, Strandvik B. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease. Hepatology. 1998, 27:166-74. 10.1002\/hep.510270126","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/adc.81.2.129","article-title":"The evolution of liver disease in cystic fibrosis","volume":"81","author":"Ling SC","year":"1999","unstructured":"Ling SC, Wilkinson JD, Hollman AS, McColl J, Evans TJ, Paton JY. The evolution of liver disease in cystic fibrosis. Arch Dis Child. 1999, 81:129-32. 10.1136\/adc.81.2.129","journal-title":"Arch Dis Child"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13526","article-title":"A rare cystic fibrosis transmembrane conductance regulator (CFTR) mutation associated with typical cystic fibrosis in an Arab child","volume":"13","author":"Mathew A","year":"2021","unstructured":"Mathew A, Dirawi M, Abou Tayoun A, Popatia R. A rare cystic fibrosis transmembrane conductance regulator (CFTR) mutation associated with typical cystic fibrosis in an Arab child. Cureus. 2021, 13:e13526. 10.7759\/cureus.13526","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-1498","article-title":"Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy","volume":"119","author":"Sims EJ","year":"2007","unstructured":"Sims EJ, Clark A, McCormick J, Mehta G, Connett G, Mehta A. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Pediatrics. 2007, 119:19-28. 10.1542\/peds.2006-1498","journal-title":"Pediatrics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/227693-a-unique-mutation-in-the-cystic-fibrosis-transmembrane-conductance-regulator-cftr-gene-causing-cystic-fibrosis-in-a-pakistani-child-a-case-highlighting-the-need-for-more-awareness","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T17:43:24Z","timestamp":1708537404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/227693-a-unique-mutation-in-the-cystic-fibrosis-transmembrane-conductance-regulator-cftr-gene-causing-cystic-fibrosis-in-a-pakistani-child-a-case-highlighting-the-need-for-more-awareness"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.54627","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,21]]}}}